| 1 | 137862-53-4 | 缬沙坦 | Valsartan | C24H29N5O3
| 药物;原料;原料药;中间体;标准品;高血压药;医药原料;医药原料药;医药中间体;抗高血压药 | 成品药 |
| 2 | 1089736-72-0 | 八氘代缬沙坦 | Valsartan-d8 | C24H29N5O3
| | |
| 3 | | Valsartan USP23 | Valsartan USP23 | C24H29N5O3
| | |
| 4 | | 缬沙坦系统适应性 | Valsartan for system suitability | C24H29N5O3
| | |
| 5 | | 缬沙坦峰值检测 | Valsartan for peak identification | C24H29N5O3
| | |
| 6 | | N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-D-valine | N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-D-valine | C24H29N5O3
| Valsartan | |
| 7 | | 3-METHYL-2-(PENTANOYL-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINO)-BUTYRIC ACID | 3-METHYL-2-(PENTANOYL-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINO)-BUTYRIC ACID | C24H29N5O3
| | |
| 8 | 102486-47-5 | | 1,2,4-Triazin-3(2H)-one, 5,6-bis(4-methoxyphenyl)-2-[2-(4-methyl-1-piperazinyl)ethyl]- | C24H29N5O3
| | |
| 9 | | N-(2-METHOXYPHENYL)-3-(4-OXO-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DEC-8-YL)AZETIDINE-1-CARBOXAMIDE | N-(2-METHOXYPHENYL)-3-(4-OXO-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DEC-8-YL)AZETIDINE-1-CARBOXAMIDE | C24H29N5O3
| | |
| 10 | | 5-(ANILINOCARBONYL)-1-[3-(1-AZEPANYL)-2-HYDROXYPROPYL]-3-PHENYL-3H-1,2,3-TRIAZOL-1-IUM-4-OLATE | 5-(ANILINOCARBONYL)-1-[3-(1-AZEPANYL)-2-HYDROXYPROPYL]-3-PHENYL-3H-1,2,3-TRIAZOL-1-IUM-4-OLATE | C24H29N5O3
| | |
| 11 | | N-(2-FURYLMETHYL)-5-(3-(4-[(1-METHYL-1H-PYRROL-2-YL)CARBONYL]PIPERAZIN-1-YL)PROPYL)NICOTINAMIDE | N-(2-FURYLMETHYL)-5-(3-(4-[(1-METHYL-1H-PYRROL-2-YL)CARBONYL]PIPERAZIN-1-YL)PROPYL)NICOTINAMIDE | C24H29N5O3
| | |
| 12 | | N-(4-ETHYLPHENYL)-2-(4-(4-METHOXYPHENYL)PIPERAZIN-1-YL)-6-OXO-3,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXAMIDE | N-(4-ETHYLPHENYL)-2-(4-(4-METHOXYPHENYL)PIPERAZIN-1-YL)-6-OXO-3,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXAMIDE | C24H29N5O3
| | |
| 13 | 1898283-02-7 | LY-3200882 | 2-(4-((4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol | C24H29N5O3
| | |